Point72 Asset Management’s DexCom DXCM Stock Holding History

Point72 Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.2K	Sell	300 -24,500	-99%	-$1.63M	﹤0.01%	3872
2026 Q1	$1.56M	Buy	24,800 +8,000	+48%	+$557K	﹤0.01%	2472
2025 Q4	$1.12M	Buy	16,800 +11,700	+229%	+$756K	﹤0.01%	2813
2025 Q3	$343K	Sell	5,100 -94,900	-95%	-$7.51M	﹤0.01%	2033
2025 Q2	$8.73M	Hold	100,000	–	–	0.02%	786
2025 Q1	$6.83M	Buy	+100,000	New	+$8.16M	0.02%	819
2023 Q3	–	Sell	-26,200	Closed	-$3.37M	–	2557
2023 Q2	$3.37M	Buy	+26,200	New	+$3.17M	0.01%	936

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Point72 Asset Management's DXCM Position: Q2 2026 in Review

Point72 Asset Management increased its DexCom (DXCM) stake by 9.9% in Q2 2026, buying an estimated $1.7M and bringing the position to 282,840 shares worth $19M. The position accounts for 0.02% of the portfolio, ranked #919.

Point72 Asset Management first reported a position in DXCM in Q4 2015 and has held it in 34 quarters since. The position peaked at $181M in Q1 2023. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Point72 Asset Management held 282,840 shares of DexCom worth $19M as of Q2 2026.
Point72 Asset Management bought 25,542 DexCom shares in Q2 2026, an estimated $1.7M.
DexCom made up 0.02% of Point72 Asset Management's portfolio in Q2 2026, its #919 holding.
Point72 Asset Management first reported a position in DexCom in Q4 2015 and has held it in 34 quarters since.
Point72 Asset Management's DexCom position peaked at $181M in Q1 2023.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.